Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00705341 · ClinicalTrials.gov registry record · Phase 4
MethaCholine Bronchoprovocation Study (MeCIS)
A Phase 4 study, sponsored by Johns Hopkins Bloomberg School of Public Health.
- Completed
- Registry status
- Phase 4
- Development phase
- 219
- Enrollment target
NCT00705341 is a Phase 4 study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 219 participants.
The verdict
NCT00705341, a Phase 4 study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 219 participants
- Enrollment target
Study Summary
The purpose of this research is to evaluate the methacholine challenge test as an accurate indicator of asthma in patients receiving treatment for asthma. Phase 1 on the study compares methacholine challenge test results from asthma patients to those from people who do not have asthma. In phase 2, test results for people with asthma on low dose inhaled corticosteroid will be compared to results on high dose inhaled corticosteroids. Both males and females with stable asthma (asthma participants) and without asthma (controls) enrolled. Participants will be between 12 and 69 years of age.
Interventions
- DRUG fluticasone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 219 participants |
| Start Date | 2009-01 |
| Est. Completion | 2010-02 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00705341
The ClinicalTrials.gov registry entry for NCT00705341 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 219 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins Bloomberg School of Public Health, which has 187 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which fluticasone is the first listed.
NCT00705341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00705341 about?
NCT00705341 is a clinical study titled "MethaCholine Bronchoprovocation Study (MeCIS)". The purpose of this research is to evaluate the methacholine challenge test as an accurate indicator of asthma in patients receiving treatment for asthma. Phase 1 on the study compares methacholine challenge test results from asthma patients to those from people who do not have asthma. In phase 2, t...
What is the current status of trial NCT00705341?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 219 participants. The study started on 2009-01. Estimated completion is 2010-02.
What interventions are being tested in trial NCT00705341?
The interventions under investigation include: fluticasone (DRUG).
Who is sponsoring clinical trial NCT00705341?
This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.